These pilot results suggest in preliminary fashion that CIAT II may produce significant improvements in everyday speech.

Objective: On March 11, 2020, the World Health Organization declared an outbreak of a new viral entity, coronavirus 2019 (COVID-19), to be a worldwide pandemic. The characteristics of this virus, as well as its short- and long-term implications, are not yet well understood. The objective of the current paper was to provide a critical review of the emerging literature on COVID-19 and its implications for neurological, neuropsychiatric, and cognitive functioning. Method: A critical review of recently published empirical research, case studies, and reviews pertaining to central nervous system (CNS) complications of COVID-19 was conducted by searching PubMed, PubMed Central, Google Scholar, and bioRxiv. Results: After considering the available literature, areas thought to be most pertinent to clinical and research neuropsychologists, including CNS manifestations, neurologic symptoms/syndromes, neuroimaging, and potential long-term implications of COVID-19 infection, were reviewed. Conclusion: Once thought to be merely a respiratory virus, the scientific and medical communities have realized COVID-19 to have broader effects on renal, vascular, and neurological body systems. The question of cognitive deficits is not yet well studied, but neuropsychologists will undoubtedly play an important role in the years to come.

These results present preliminary evidence for the reliability and validity of the VAL and spoken language recording for assessment of the amount of real-world spoken language in aphasia. As a simple patient-reported outcome, the VAL may assist diverse therapies for aphasia.

Objective Depressive symptoms after stroke have been associated with negative outcomes, including poorer functional ability, less efficient use of rehabilitation services, decreased quality of life, and increased mortality. It has been anecdotally noted that depressive symptoms do not limit motor recovery in patients who undergo Constraint-Induced Movement therapy (CIMT), an efficacious intervention for chronic post-stroke hemiparesis. Here we analyze depressive symptom and motor scores from 40 participants who received CIMT in two previously published studies. Method Adults more than 1-year after stroke with mild to moderate upper-extremity hemiparesis completed the Zung Self-Rating Depression Scale and Motor Activity Log (MAL) before and after CIMT. We used regression analysis to test whether Zung scores predicted response to CIMT and paired t-tests to test whether depressive symptoms changed from pre- to post-treatment. Results Pre-treatment Zung score did not predict outcome on the MAL Arm Use scale, ΔR2 (1,30) = 0.004, p = .19, after controlling for pre-treatment MAL scores. Additionally, participants had a small but statistically significant decrease in Zung score, t(39) = 3.0, p = 0.005, mean change = −3.6. Conclusions These results suggest that depressive symptoms do not significantly limit motor recovery in patients treated with CIMT for chronic post-stroke hemiparesis. Additionally, treatment with CIMT may improve depressive symptoms.

Relaxation training or mindfulness meditation PMR, diaphragmatic breathing, guided imagery, MBSR Activity modification Behavioral Activation/Pleasant Events Scheduling Promoting change Motivational Interviewing (Watkins et al., 2011) Cognitive reframing CBT (Broomfield et al., 2011)